Facing a PR crisis and the loss of major government contracts for its main anthrax vaccine, Emergent, a biopharmaceutical group, was in a battle for survival.

The CEO turned to TM to help position its brand, repair its damaged reputation and prepare for an IPO.

/research /naming /brand architecture /brand strategy /message platform /logo /visual identity /website /pitch deck /collateral /signage /brand training /brand launch /brand implementation